Business ❯ Corporate Law

Securities

Investor Relations Stock Market Public Offerings Pharmaceutical Industry Stockholder Rights Biotechnology Initial Public Offering Software Industry Stock Purchases Public Companies

Investors File Securities Suit Against Grail as Firms Race for Lead‑Plaintiff Role

A contested fight for lead‑plaintiff status will determine which counsel directs discovery and could shape any recovery for investors.

Class Action Filed Against GRAIL Over NHS‑Galleri Trial Disclosures as Law Firms Seek Lead Plaintiffs

Multiple Law Firms File Class Action Over Lucid’s Disclosure of Gravity Delivery Problems

Law Firms File Securities Suits Against AeroVironment Over Alleged Misleading Space‑Program Claims

Gartner Investors Urged to Seek Lead-Plaintiff Role as May 18 Deadline Nears

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

LKQ Faces Securities Class Action Over FinishMaster Deal and Disclosures

Investor Lawsuits Target ODDITY Over Ad-Algorithm Disruption as Lead-Plaintiff Deadline Nears

Nektar Securities Suit Urges Investors To Seek Lead‑Plaintiff Status Before May 5

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Rosen Law Firm Urges Hercules Capital Investors to Seek Lead Role Before May 19 Deadline

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Richtech Investors Face Friday Deadline in Lawsuit Over Microsoft Tie Claims

Monday.com Investors Press Securities Class Action as May 11 Lead-Plaintiff Deadline Nears

Richtech Robotics Faces Wave of Securities Suits Over Microsoft Claims as Lead Plaintiff Deadline Nears

CoreWeave Faces Securities Class Action Over Data-Center Delays and Demand Claims

Fermi Faces SDNY Securities Class Action Over IPO Disclosures as March 6 Lead-Plaintiff Deadline Nears

Integer Securities Class Action Moves Forward as Investors Face Feb. 9 Lead-Plaintiff Deadline

Fermi Sued in SDNY After $150 Million Project Matador Funding Is Terminated

Stride Securities Fight Intensifies as Firms Urge Investors to Meet Jan. 12 Lead-Plaintiff Deadline